Donald Trump needed just 20 minutes to knock $24.6 billion in value from the nine biggest Big Pharma companies. That was the statistic bandied about recently when the president-elect, at a much-anticipated press conference, declared that pharmaceuticals are “getting away with murder.”
That’s ironic, because investors targeting the sure-fire dividends of Big Pharma stocks might be able to get away with theft.
